ALEXANDRA LINDSEY: Open Payments
NPI 1932505567 · NOVI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,279 in 65 payments from 16 companies in 2025. Trend: 2023 $750 · 2024 $975 · 2025 $1,279
Food & beverage: $1,279
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $307 |
| ABBVIE INC. | 13 | $256 |
| PFIZER INC. | 10 | $149 |
| AstraZeneca Pharmaceuticals LP | 7 | $110 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| Abbott Laboratories | 3 | $66 |
| Lilly USA, LLC | 3 | $50 |
| Exact Sciences Corporation | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
Products named: Ozempic, VRAYLAR, Auvelity, Wegovy, QULIPTA, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, FARXIGA.
Industry payments across MI — which companies pay providers there.
